down arrow

Gufic BioScience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE742B01025
  • NSEID: GUFICBIO
  • BSEID: 509079
INR
322.15
8.85 (2.82%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 26.3 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Net Sales
614.78
611.67
Other Operating Income
0.00
0.00
Total Operating income
614.78
611.67
Raw Material Cost
221.29
250.37
Purchase of Finished goods
44.57
43.72
(Increase) / Decrease In Stocks
19.18
7.19
Employee Cost
91.48
80.75
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
129.95
118.00
Total Expenditure (Excl Depreciation)
506.47
500.03
Operating Profit (PBDIT) excl Other Income
108.31
111.64
Other Income
3.23
1.29
Operating Profit (PBDIT)
111.54
112.93
Interest
14.71
11.71
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
96.83
101.22
Depreciation
13.22
12.67
Profit Before Tax
83.62
88.55
Tax
21.69
22.46
Provisions and contingencies
0.00
0.00
Profit After Tax
61.93
66.09
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
61.93
66.09
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
61.93
66.09
Equity Capital
10.03
10.03
Face Value
1.0
1.0
Reserves
0.00
0.00
Diluted Earnings per share
1.93
2.23
Operating Profit Margin (Excl OI)
17.62%
18.25%
Gross Profit Margin
15.75%
16.55%
PAT Margin
10.07%
10.8%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2024 is 0.51% vs 18.18% in Dec 2023

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -6.26% vs 7.29% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2024 is -2.96% vs 11.34% in Dec 2023

stock-summary

Interest

YoY Growth in nine months ended Dec 2024 is 25.62% vs 140.95% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023

Compare Nine Monthly Results Of Gufic BioScience With
Markets Mojo
Figures in Rs cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
614.78
9,199.93
-8,585.15
-93.32%
Other Operating Income
0.00
0.00
0.00
Total Operating income
614.78
9,199.93
-8,585.15
-93.32%
Raw Material Cost
221.29
1,471.08
-1,249.79
-84.96%
Purchase of Finished goods
44.57
1,244.57
-1,200.00
-96.42%
(Increase) / Decrease In Stocks
19.18
-93.01
112.19
120.62%
Employee Cost
91.48
1,989.92
-1,898.44
-95.40%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
129.95
2,225.77
-2,095.82
-94.16%
Total Expenditure (Excl Depreciation)
506.47
6,838.33
-6,331.86
-92.59%
Operating Profit (PBDIT) excl Other Income
108.31
2,361.60
-2,253.29
-95.41%
Other Income
3.23
287.35
-284.12
-98.88%
Operating Profit (PBDIT)
111.54
2,648.95
-2,537.41
-95.79%
Interest
14.71
238.94
-224.23
-93.84%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
96.83
2,410.01
-2,313.18
-95.98%
Depreciation
13.22
405.66
-392.44
-96.74%
Profit Before Tax
83.62
2,007.79
-1,924.17
-95.84%
Tax
21.69
427.80
-406.11
-94.93%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
61.93
1,576.55
-1,514.62
-96.07%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
61.93
1,576.55
-1,514.62
-96.07%
Share in Profit of Associates
0.00
9.92
-9.92
-100.00%
Minority Interest
0.00
-7.70
7.70
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
61.93
1,570.19
-1,508.26
-96.06%
Equity Capital
10.03
40.06
-30.03
-74.96%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
15.75%
26.20%
0.00
-10.45%
PAT Margin
10.07%
17.14%
0.00
-7.07%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 614.78 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 0.51% vs 18.18% in Dec 2023

Nine Monthly - Standalone Net Profit
Standalone Net Profit 61.95 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is -6.26% vs 7.29% in Dec 2023

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 108.34 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is -2.96% vs 11.34% in Dec 2023

Nine Monthly - Interest
Interest 14.71 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 25.62% vs 140.95% in Dec 2023

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.62%
in Dec 2024

Figures in Rs %
stock-summary

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023